BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21179284)

  • 1. Thalidomide induced nonspecific interstitial pneumonia in patient with relapsed multiple myeloma.
    Kang MH; Ju JH; Kim HG; Kang JH; Jeon KN; Kim HC; Lee GW
    Korean J Intern Med; 2010 Dec; 25(4):447-9. PubMed ID: 21179284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case of thalidomide-induced interstitial pneumonia].
    Matsushima H; Oda T; Yamamoto M; Sato A; Hasejima N; Takezawa S
    Nihon Kokyuki Gakkai Zasshi; 2009 May; 47(5):438-42. PubMed ID: 19514509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interstitial pneumonitis as an adverse effect of thalidomide].
    Scholte JB; Potjewijd J; Voogt PJ; Custers FL; Jie KS
    Ned Tijdschr Geneeskd; 2009; 153():A452. PubMed ID: 20051154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interstitial pneumonia during treatment with thalidomide in a patient with multiple myeloma].
    Iguchi T; Sakoda M; Chen CK; Yokoyama K; Hattori Y; Ikeda Y; Okamoto S
    Rinsho Ketsueki; 2004 Sep; 45(9):1064-6. PubMed ID: 15510838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interstitial pneumonitis as an adverse effect of thalidomide].
    Scholte JB; Potjewijd J; Voogt PJ; Custers FL; Lie KS
    Ned Tijdschr Geneeskd; 2009; 153():A452. PubMed ID: 19785872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide may induce interstitial pneumonia preferentially in Japanese patients.
    Sasaki M; Isobe Y; Tsukune Y; Kawahara S; Hamano Y; Ando J; Tomomatsu J; Tsutsui M; Sugimoto K
    Eur J Haematol; 2009 Jan; 82(1):73-4. PubMed ID: 18754854
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonspecific interstitial pneumonitis after bortezomib and thalidomide treatment in a multiple myeloma patient.
    Kang W; Kim JS; Cho SH; Kim SK; Chang J; Park MS
    Yonsei Med J; 2010 May; 51(3):448-50. PubMed ID: 20376900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide-induced bronchiolitis obliterans organizing pneumonia in a patient with multiple myeloma.
    El Ati Z; Lamia R; Cherif J; Jbali H; Fatma LB; Mami I; Khedher R; Smaoui W; Krid M; Hamida FB; Beji S; Zouaghi MK
    Saudi J Kidney Dis Transpl; 2019; 30(4):974-977. PubMed ID: 31464258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side effects and good effects from new chemotherapeutic agents. Case 2. Thalidomide-induced interstitial pneumonitis.
    Onozawa M; Hashino S; Sogabe S; Haneda M; Horimoto H; Izumiyama K; Kondo T; Aldana LP; Hamada K; Asaka M
    J Clin Oncol; 2005 Apr; 23(10):2425-6. PubMed ID: 15800335
    [No Abstract]   [Full Text] [Related]  

  • 10. Lenalidomide-induced interstitial lung disease.
    Chen Y; Kiatsimkul P; Nugent K; Raj R
    Pharmacotherapy; 2010 Mar; 30(3):325. PubMed ID: 20180616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung Toxicity after Lenalidomide Treatment in a Patient with Multiple Myeloma.
    Cabrera César E; Fernández Aguirre MC; González Fernández A
    Arch Bronconeumol; 2017 Jun; 53(6):355-356. PubMed ID: 27939513
    [No Abstract]   [Full Text] [Related]  

  • 12. Pomalidomide-Induced Pulmonary Toxicity in Multiple Myeloma.
    Modi D; Mamdani H; Vettese T
    Am J Med Sci; 2015 Sep; 350(3):241-2. PubMed ID: 26200951
    [No Abstract]   [Full Text] [Related]  

  • 13. Interstitial pneumonitis associated with the immunomodulatory drugs thalidomide and lenalidomide.
    Iino M
    Int J Hematol; 2012 Feb; 95(2):223-4. PubMed ID: 22198829
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversible pulmonary toxicity due to lenalidomide.
    Coates S; Barker A; Spurgeon S
    J Oncol Pharm Pract; 2012 Jun; 18(2):284-6. PubMed ID: 21742815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propylthiouracil-induced nonspecific interstitial pneumonia.
    Lee JY; Chung JH; Lee YJ; Park SS; Kim SY; Koo HK; Lee JH; Lee CT; Yoon HI
    Chest; 2011 Mar; 139(3):687-690. PubMed ID: 21362656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide-induced reversible interstitial pneumonitis in a patient with recurrent ovarian cancer.
    Buttin BM; Moore MJ
    Gynecol Oncol; 2008 Dec; 111(3):546-8. PubMed ID: 18191185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive dyspnea and diffuse ground-glass opacities after treatment for lymphoma with rituximab-containing chemotherapy: A case report.
    Sun Y; Shao C; Xu K; Li J; Zhang Y; Liu P; Huang H; Feng R
    Thorac Cancer; 2020 Jul; 11(7):2040-2043. PubMed ID: 32374517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients.
    Cottin V; Donsbeck AV; Revel D; Loire R; Cordier JF
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1286-93. PubMed ID: 9769293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrent multiple lung lesions synchronizing with the disease activity of multiple myeloma].
    Matsuoka S; Hosono N; Matsuda Y; Oiwa K; Ookura M; Tai K; Anzai M; Nemoto T; Ishizuka T; Nakamoto Y; Yamauchi T
    Rinsho Ketsueki; 2017; 58(12):2406-2410. PubMed ID: 29332875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis induced by thalidomide in a patient with multiple myeloma.
    Ferrazzi A; Zambello R; Russo I; Alaibac M
    BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24973347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.